Please use this identifier to cite or link to this item:
http://repositorio.ufla.br/jspui/handle/1/43151| metadata.artigo.dc.title: | What to expect from different drugs used in the treatment of COVID-19: a study on applications and in vivo and in vitro results |
| metadata.artigo.dc.creator: | Marcolino, Vanessa Aparecida Pimentel, Tatiana Colombo Barão, Carlos Eduardo |
| metadata.artigo.dc.subject: | Chloroquine Antivirals Dexamethasone Ivermectin Anticoagulants |
| metadata.artigo.dc.publisher: | Elsevier |
| metadata.artigo.dc.date.issued: | Nov-2020 |
| metadata.artigo.dc.identifier.citation: | MARCOLINO, V. A.; PIMENTEL, T. C.; BARÃO, C. E. What to expect from different drugs used in the treatment of COVID-19: a study on applications and in vivo and in vitro results. European Journal of Pharmacology, [S.l.], v. 887, Nov. 2020. |
| metadata.artigo.dc.description.abstract: | The end of 2019 was marked by the emergence of a new type of coronavirus (SARS-CoV-2), which has killed more than 240,000 people around the world so far. Several clinical studies are being performed to test possible drugs in response to the COVID-19 outbreak; however, there is still no treatment that is completely effective. Our goal in this paper is to bring together the results of main studies carried out with different drugs in order to help spread the knowledge about possible treatments for COVID-19 that have been suggested so far. |
| metadata.artigo.dc.identifier.uri: | https://www.sciencedirect.com/science/article/pii/S0014299920305598#! http://repositorio.ufla.br/jspui/handle/1/43151 |
| metadata.artigo.dc.language: | en_US |
| Appears in Collections: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.